Kidney Transplantation
Screening for hepatitis B virus DNA doesn't worsen donor organ shortage
Published in Hepatitis Weekly, July 7th, 2003
"In order to determine the impact of screening potential organ donors for hepatitis B virus DNA using a standardized test, the serum of 145 donor candidates was tested. All of the candidates were negative for hepatitis B virus DNA, but the status of one donor was doubtful for hepatitis B virus surface antigen and seven donors tested positive for hepatitis B virus core antibody without hepatitis B virus surface antigen," scientists writing in the European Journal of Clinical Microbiology and Infectious Diseases reported.
"Nine transplant recipients tested positive for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-07-07)
More Articles from Hepatitis Weekly
- Hemophilia
HCV-positive hemophiliacs get comprehensive cancer therapy with surveillance - Hepatocellular Carcinoma
Zinc finger transcription factor defines treatment-sensitive liver cancer - Autoimmune Disease
Proper diagnosis and awareness of autoimmune hepatitis compels better survival - Chronic Hepatitis C
Interferon-alpha(2b) induction with ribavirin posts better results against HCV - Hepatology
Obese rats avoid the development of fatty liver with exercise - Blood Safety
Pakistani injection drug users twice as likely to donate blood - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
